Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of ...

Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

One the bigger drivers of Medicaid’s rising costs is the ballooning expense of covering weight loss drugs, a state Senate ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

Compounded GLP-1 medications are typically safe for most people. But since compounded GLP-1s aren’t FDA-approved, the FDA ...

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...